Nir Barzlai, M.D., founded the Institute for Aging Research at the Albert Einstein College of Medicine over twenty years ago. His most fascinating study features a patient population of 600 centenarians - individuals who maintain active lives well into their 90s and 100s - and, more importantly, reached that milestone never having experienced the so-called big four: cardiovascular disease, cancer, diabetes and cognitive decline.
Dr. Barzlai identified three clusters of genetic mutations - connected to levels of cholesterol, growth hormones and peptides produced in their cells' mitochondria - that correlate to centenarians' enviable lifespan and healthspan. In Age Later, he translates those findings to news readers can use - including taking melatonin and using intermittent fasting - to mimic some of the effects of the 'super agers'' genetic code.
Sprache
Verlagsort
Maße
Höhe: 242 mm
Breite: 163 mm
Dicke: 28 mm
Gewicht
ISBN-13
978-1-250-23085-0 (9781250230850)
Copyright in bibliographic data and cover images is held by Nielsen Book Services Limited or by the publishers or by their respective licensors: all rights reserved.
Schweitzer Klassifikation
NIR BARZILAI, M.D., is the founding Director of the Institute for Aging Research at Albert Einstein College of Medicine and the Nathan Shock Center for Excellence in the Basic Biology of Aging, and discovered the first longevity gene in humans. He is also the director of the Diabetes Research and Training Center Physiology Core and the co-director of the Montefiore Hospital Diabetes Clinic.
